10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001683168-19-002639`
Period End Date	20190630
Filing Date	20190814
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	xbio-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 41 Cash Flow Statement 46 Stockholders Equity 34

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	12.50M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	12.50M	shares	Point-in-time
Cash	`Cash`	$571.61K	USD	Point-in-time
Cash	`Cash`	$1.03M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	949,218.00	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	810,856.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	922,227.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	783,865.00	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	-	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$555.86K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.35M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.39M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.19M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.96K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.54K	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$705.66K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$715.39K	USD	Point-in-time
Total assets	`Assets`	$15.63M	USD	Point-in-time
Total assets	`Assets`	$14.43M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.02M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$934.15K	USD	Point-in-time
Accrued expenses and other current liabilities	`OtherLiabilitiesCurrent`	$665.64K	USD	Point-in-time
Accrued expenses and other current liabilities	`OtherLiabilitiesCurrent`	$1.29M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.32M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.60M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$6.18K	USD	Point-in-time
Total liabilities	`Liabilities`	$4.52M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.24M	USD	Point-in-time
Commitments (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 12,500,000 shares authorized as of June 30, 2019 and December 31, 2018; 949,218 and 810,856 shares issued as of June 30, 2019 and December 31, 2018, respectively; 922,227 and 783,865 shares outstanding as of June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$811.00	USD	Point-in-time
Common stock, $0.001 par value; 12,500,000 shares authorized as of June 30, 2019 and December 31, 2018; 949,218 and 810,856 shares issued as of June 30, 2019 and December 31, 2018, respectively; 922,227 and 783,865 shares outstanding as of June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$948.00	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$171.35M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$168.17M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-155.94M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-153.23M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.89M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.39M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.78M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.52M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.30M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$15.63M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$14.43M	USD	Point-in-time

Income Statement 41 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$1.63M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$487.52K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$927.07K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$951.30K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.07M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.19M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.75M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$890.78K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.38M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.71M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.99M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.82M	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$735.00	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$490.00	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-27.13K	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-32.53K	USD	1 Quarter
Interest income (expense)	`InterestIncomeExpenseNet`	$-61.00	USD	1 Quarter
Interest income (expense)	`InterestIncomeExpenseNet`	$366.00	USD	2 Qtrs
Interest income (expense)	`InterestIncomeExpenseNet`	$313.00	USD	2 Qtrs
Interest income (expense)	`InterestIncomeExpenseNet`	$163.00	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-32.59K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$803.00	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-26.77K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$898.00	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.85M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.70M	USD	2 Qtrs
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	$3.88M	USD	2 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.58M	USD	2 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.03M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.38M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.85M	USD	2 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-7.79	USD	2 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-5.29	USD	2 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-2.78	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-1.56	USD	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	844,749.00	shares	2 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	727,697.00	shares	2 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	728,929.00	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	882,107.00	shares	1 Quarter

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.85M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.70M	USD	2 Qtrs
Depreciation	`Depreciation`	$2.41K	USD	2 Qtrs
Depreciation	`Depreciation`	$1.00K	USD	1 Quarter
Depreciation	`Depreciation`	$11.40K	USD	2 Qtrs
Depreciation	`Depreciation`	$5.00K	USD	1 Quarter
Amortization of right of use asset	`FinanceLeaseRightOfUseAssetAmortization`	$10.18K	USD	2 Qtrs
Amortization of right of use asset	`FinanceLeaseRightOfUseAssetAmortization`	-	USD	2 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$2.00K	USD	2 Qtrs
Share-based expense	`ShareBasedCompensation`	$450.67K	USD	2 Qtrs
Share-based expense	`ShareBasedCompensation`	$816.95K	USD	2 Qtrs
Vendor share-based expense	`VendorShareBasedCompensation`	$34.85K	USD	2 Qtrs
Vendor share-based expense	`VendorShareBasedCompensation`	$32.43K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$379.88K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$775.26K	USD	2 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$680.77K	USD	2 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-389.57K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.31M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.75M	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOrSaleOfEquity`	$2.70M	USD	2 Qtrs
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOrSaleOfEquity`	$1.48M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.70M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.48M	USD	2 Qtrs
Net change in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-2.27M	USD	2 Qtrs
Net change in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$396.10K	USD	2 Qtrs
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.03M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.32M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.60M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.03M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.32M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.60M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$8.00	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$678.00	USD	2 Qtrs
Right of use asset acquired in exchange for lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Right of use asset acquired in exchange for lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$43.33K	USD	2 Qtrs
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	-	USD	2 Qtrs
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	$316.00	USD	2 Qtrs

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$12.89M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$10.39M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$12.78M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$11.52M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$14.30M	USD	Point-in-time
Issuance of common stock and warrants in registered direct offering, net of issuance costs, value	`StockIssuedDuringPeriodValueNewIssues`	$2.70M	USD	2 Qtrs
Exercise of pre-funded warrant, value	`ExerciseOfPrefundedWarrantValue`	$509.00	USD	2 Qtrs
Exercise of pre-funded warrant, value	`ExerciseOfPrefundedWarrantValue`	$509.00	USD	1 Quarter
Exercise of warrants, value	`StockIssuedForExerciseOfWarrantsValue`	$1.48M	USD	1 Quarter
Exercise of warrants, value	`StockIssuedForExerciseOfWarrantsValue`	$1.48M	USD	2 Qtrs
Issuance of common stock to vendor, value	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	1 Quarter
Issuance of common stock to adjust for reverse split rounding, value	`StockIssuedDuringPeriodValueOther`	-	USD	1 Quarter
Deemed dividend related to Series B Preferred Stock down round provision	`DeemedDividendRelatedToSeriesBPreferredStockDownRoundProvision`	$3.88M	USD	2 Qtrs
Accretion of deemed dividend related to Series B Preferred Stock down round provision	`OtherPreferredStockDividendsAndAdjustments`	$3.88M	USD	2 Qtrs
Conversion of Series B preferred stock to shares of common stock, value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	2 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$450.68K	USD	2 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$428.18K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$816.95K	USD	2 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$234.15K	USD	1 Quarter
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$15.00K	USD	1 Quarter
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$17.43K	USD	1 Quarter
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$32.43K	USD	2 Qtrs
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$34.85K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.85M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.70M	USD	2 Qtrs
Ending balance, value	`StockholdersEquity`	$12.89M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$10.39M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$12.78M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$11.52M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$14.30M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.